- Report
- January 2023
- 166 Pages
Asia Pacific
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- January 2023
- 135 Pages
Middle East, Africa
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- October 2022
- 209 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- August 2022
- 104 Pages
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- March 2022
- 198 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- April 2023
- 112 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- March 2022
- 124 Pages
Global
From €4302EUR$4,450USD£3,695GBP
- Report
- January 2019
- 105 Pages
Global
From €4157EUR$4,300USD£3,571GBP
- Report
- June 2021
- 54 Pages
Global
€21269EUR$22,000USD£18,269GBP
- Report
- October 2020
- 51 Pages
Global
€21269EUR$22,000USD£18,269GBP
- Report
- October 2020
- 57 Pages
Global
- Report
- January 2019
- 12 Pages
Global
From €9668EUR$10,000USD£8,304GBP
- Report
- January 2019
- 12 Pages
Global
From €9668EUR$10,000USD£8,304GBP
- Report
- January 2019
- 12 Pages
Global
From €9668EUR$10,000USD£8,304GBP
- Report
- January 2019
- 12 Pages
Global
From €9668EUR$10,000USD£8,304GBP
- Report
- January 2019
- 14 Pages
Global
From €9668EUR$10,000USD£8,304GBP
- Report
- December 2019
- 104 Pages
Asia Pacific
From €8696EUR$8,995USD£7,470GBP
- Report
- October 2019
- 157 Pages
Global
From €10630EUR$10,995USD£9,130GBP
- Report
- November 2022
- 160 Pages
Global
€3287EUR$3,400USD£2,823GBP
The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions.
Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques.
Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more